K. Steven LaForge

5.9k total citations · 2 hit papers
50 papers, 4.4k citations indexed

About

K. Steven LaForge is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Surgery. According to data from OpenAlex, K. Steven LaForge has authored 50 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Cellular and Molecular Neuroscience, 20 papers in Molecular Biology and 8 papers in Surgery. Recurrent topics in K. Steven LaForge's work include Neuropeptides and Animal Physiology (20 papers), Neurotransmitter Receptor Influence on Behavior (16 papers) and Receptor Mechanisms and Signaling (9 papers). K. Steven LaForge is often cited by papers focused on Neuropeptides and Animal Physiology (20 papers), Neurotransmitter Receptor Influence on Behavior (16 papers) and Receptor Mechanisms and Signaling (9 papers). K. Steven LaForge collaborates with scholars based in United States, Sweden and China. K. Steven LaForge's co-authors include Mary Jeanne Kreek, David A. Nielsen, Eduardo R. Butelman, Pravinkumar B. Sehgal, Anuradha Ray, Ann Ho, Vadim Yuferov, Gavin Bart, Suzanne M. Leal and Lisa Borg and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Neuroscience.

In The Last Decade

K. Steven LaForge

50 papers receiving 4.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Single-nucleotide polymorphism in the human mu opioid receptor gene alters β-endorphin binding and activity: Possible implications for opiate addiction

1998 855 citations K. Steven LaForge, Suzanne M. Leal et al. profile →
Genetic influences on impulsivity, risk taking, stress responsivity and vulnerability to drug abuse and addiction

2005 753 citations Mary Jeanne Kreek, David A. Nielsen et al. Nature Neuroscience profile →

Peers

Countries citing papers authored by K. Steven LaForge

Since Specialization

Citations

This map shows the geographic impact of K. Steven LaForge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Steven LaForge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Steven LaForge more than expected).

Fields of papers citing papers by K. Steven LaForge

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Steven LaForge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Steven LaForge. The network helps show where K. Steven LaForge may publish in the future.

Co-authorship network of co-authors of K. Steven LaForge

This figure shows the co-authorship network connecting the top 25 collaborators of K. Steven LaForge. A scholar is included among the top collaborators of K. Steven LaForge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Steven LaForge. K. Steven LaForge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Catechol‐O‐methyltransferase (COMT) gene variants: Possible association of the Val158Met variant with opiate addiction in hispanic women 2008 ·American Journal of Medical Genetics Part B Neuropsychiatric Genetics ·(unknown), K. Steven LaForge, Dmitri Proudnikov, Ann Ho, David A. Nielsen, Robert Gianotti, Sandra Barral, Derek Gordon, Suzanne M. Leal, Jürg Ott, Mary Jeanne Kreek	26
2	Stress Responsivity, Addiction, and a Functional Variant of the Human Mu-Opioid Receptor Gene 2007 ·Molecular Interventions ·M J Kreek, K. Steven LaForge	38
3	The single nucleotide polymorphism A118G alters functional properties of the human mu opioid receptor 2007 ·Journal of Neurochemistry ·Thomas Kroslak, K. Steven LaForge, Robert Gianotti, Ann Ho, David A. Nielsen, Mary Jeanne Kreek	165
4	Association analysis of polymorphisms in serotonin 1B receptor (HTR1B) gene with heroin addiction: a comparison of molecular and statistically estimated haplotypes 2006 ·Pharmacogenetics and Genomics ·Dmitri Proudnikov, K. Steven LaForge, Heather Hofflich, Mark A. Levenstien, Derek Gordon, Sandra Barral, Jürg Ott, Mary Jeanne Kreek	39
5	Pharmacogenetics and Human Molecular Genetics of Opiate and Cocaine Addictions and Their Treatments 2005 ·Pharmacological Reviews ·Mary Jeanne Kreek, Gavin Bart, Charles Lilly, K. Steven LaForge, David A. Nielsen	278
6	Genetic influences on impulsivity, risk taking, stress responsivity and vulnerability to drug abuse and addiction breakdown → 2005 ·Nature Neuroscience ·Mary Jeanne Kreek, David A. Nielsen, Eduardo R. Butelman, K. Steven LaForge	753
7	Genes Associated With Addiction: Alcoholism, Opiate, and Cocaine Addiction 2004 ·NeuroMolecular Medicine ·Mary Jeanne Kreek, David A. Nielsen, K. Steven LaForge	102
8	High-throughput molecular haplotype analysis (allelic assignment) of single-nucleotide polymorphisms by fluorescent polymerase chain reaction 2004 ·Analytical Biochemistry ·Dmitri Proudnikov, K. Steven LaForge, Mary Jeanne Kreek	7
9	Acute ‘binge’ cocaine administration elevates dynorphin mRNA in the caudate putamen of C57BL/6J but not 129/J mice 2003 ·Brain Research ·Stefan D. Schlussman, Yong Zhang, Vadim Yuferov, K. Steven LaForge, Ann Ho, Mary Jeanne Kreek	23
10	Differential gene expression in the rat caudate putamen after “binge” cocaine administration: Advantage of triplicate microarray analysis 2003 ·Synapse ·Vadim Yuferov, Thomas Kroslak, K. Steven LaForge, Yan Zhou, Ann Ho, Mary Jeanne Kreek	124
11	Quantification of multiple mRNA levels in rat brain regions using real time optical PCR 2003 ·Molecular Brain Research ·Dmitri Proudnikov, Vadim Yuferov, K. Steven LaForge, Ann Ho, Mary Jeanne Kreek	11
12	Potentially functional polymorphism in the promoter region of prodynorphin gene may be associated with protection against cocaine dependence or abuse 2002 ·American Journal of Medical Genetics ·Andrew C. H. Chen, K. Steven LaForge, Ann Ho, Pauline McHugh, Scott Kellogg, Kathy Bell, (unknown), Suzanne M. Leal, Mary Jeanne Kreek	63
13	“Binge” cocaine differentially alters preproenkephalin mRNA levels in guinea pig brain 2002 ·Brain Research Bulletin ·K. Steven LaForge, Vadim Yuferov, Yan Zhou, Ann Ho, Fred Nyberg, Mary Jeanne Kreek	8
14	Pharmacotherapy of addictions 2002 ·Nature Reviews Drug Discovery ·Mary Jeanne Kreek, K. Steven LaForge, Eduardo R. Butelman	292
15	Novel and previously reported single‐nucleotide polymorphisms in the human 5‐HT_1B receptor gene: No association with cocaine or alcohol abuse or dependence 2001 ·American Journal of Medical Genetics ·Tessa Cigler, K. Steven LaForge, Pauline McHugh, (unknown), Suzanne M. Leal, Mary Jeanne Kreek	43
16	Distribution of nociceptin/orphanin FQ receptor transcript in human central nervous system and immune cells 1998 ·Journal of Neuroimmunology ·Jean Peluso, K. Steven LaForge, Hans W. D. Matthes, Mary Jeanne Kreek, Brigitte L. Kieffer, Claire Gavériaux‐Ruff	112
17	Comparison of Methods for Quantitation of Radioactivity in Protected Hybrids in RNase Protection Assays 1998 ·BioTechniques ·(unknown), K. Steven LaForge, Mary Jeanne Kreek	11
18	Guinea Pig Preprodynorphin mRNA: Primary Structure and Regional Quantitation in the Brain 1996 ·DNA and Cell Biology ·Vadim Yuferov, K. Steven LaForge, Rudolph Spangler, (unknown), Mary Jeanne Kreek	14
19	Modulation of CRF-R1 mRNA in rat anterior pituitary by dexamethasone: Correlation with POMC mRNA 1996 ·Peptides ·Yan Zhou, Rudolph Spangler, K. Steven LaForge, Christopher E. Maggos, Ann Ho, Mary Jeanne Kreek	44
20	Steady-state methadone in rats does not change mRNA levels of corticotropin-releasing factor, its pituitary receptor or proopiomelanocortin 1996 ·European Journal of Pharmacology ·Yan Zhou, Rudolph Spangler, Christopher E. Maggos, K. Steven LaForge, Ann Ho, Mary Jeanne Kreek	32

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact